Enhanced cytotoxicity of doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres against multidrug-resistant tumour cells in culture
- 31 December 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (1) , 89-93
- https://doi.org/10.1016/s0959-8049(05)80025-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Pharmacological and molecular characterization of intrinsic and acquired doxorubicin resistance in murine tumor cell linesZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Clinical Correlates of MDR1 (P-glycoprotein) Gene Expression in Ovarian and Small-Cell Lung CarcinomasJNCI Journal of the National Cancer Institute, 1992
- Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistanceBiochemical Pharmacology, 1992
- P-glycoprotein overexpression cannot explain the complete doxorubicin-resistance phenotype in rat glioblastoma cell linesBritish Journal of Cancer, 1992
- Multifactorial resistance in LS174T human colon carcinoma cells selected with doxorubicinInternational Journal of Cancer, 1991
- Nanoparticles as microcarriers for anticancer drugsAdvanced Drug Delivery Reviews, 1990
- Multiple-Drug Resistance in Human CancerNew England Journal of Medicine, 1987
- Cellular Pharmacology of Doxorubicin in Sensitive and Resistant Rat Glioblastoma Cells in CultureOncology, 1986
- Toxicity of Polyalkylcyanoacrylate Nanoparticles II: Doxorubicin-Loaded NanoparticlesJournal of Pharmaceutical Sciences, 1982
- Differentiated Rat Glial Cell Strain in Tissue CultureScience, 1968